Murali Ramachandran
SEC CIK 1870016 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KAPA | Kairos Pharma, LTD. | VP of Research, Development | 299.5K | $318 | — | 3 | 2024-11-25 | 2025-10-08 |
Most active insiders at KAPA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samuelson Doug | CFO | — | — |
| 2 | Bhowmick Neil | CSO | — | — |
| 3 | Murali Ramachandran | VP of Research, Development | — | — |
| 4 | Yu John S | CEO, COB, Dir, 10% | — | — |
| 5 | Singhvi Rahul | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 2025-10-08 | KAPA | Kairos Pharma, LTD. | Murali Ramachandran | VP of Research, Development | A - Grant | $0.00 | +152.7K | 299.5K | +104% | $0 | |
| 2025-02-24 | 2025-01-01 | KAPA | Kairos Pharma, LTD. | Murali Ramachandran | VP of Research, Development | A - Grant | $0.00 | +14.0K | 147.1K | +11% | $0 | |
| 2024-11-25 | 2024-11-25 | KAPA | Kairos Pharma, LTD. | Murali Ramachandran | VP of Research, Development | P - Purchase | $1.59 | +200 | 133.1K | +0.2% | +$318 |
Purchase Sale Sale after option exercise All abbreviations